HBI Deals+Insights / Payor and Operator Models

“Very profitable” Ober Scharrer heading for a sale?

Rumour has it that German ophthalmology chain Ober Scharrer will be sold in the winter. Of course, its CEO Sibylle Stauch-Eckmann couldn’t possibly comment. Nonetheless, she tells us the group now has 5% of the country’s rapidly consolidating eye-care market and a strong pipeline offering further growth.

We would welcome your thoughts on this story. Email your views to Claude Risner or call 0207 183 3779.